Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETON
· Real-Time Price · USD
20.27
0.13 (0.65%)
At close: Sep 26, 2025, 11:06 AM
0.65% (1D)
| Bid | 20.23 |
| Market Cap | 543.59M |
| Revenue (ttm) | 58.18M |
| Net Income (ttm) | -4.13M |
| EPS (ttm) | -0.15 |
| PE Ratio (ttm) | -135.13 |
| Forward PE | 19.35 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 20.3 |
| Volume | 56,329 |
| Avg. Volume (20D) | 420,174 |
| Open | 20.31 |
| Previous Close | 20.14 |
| Day's Range | 19.83 - 20.31 |
| 52-Week Range | 5.63 - 21.48 |
| Beta | 1.11 |
| Ex-Dividend Date | n/a |
About ETON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ETON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ETON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEton Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+0%
Eton Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+9.8%
Eton Pharmaceuticals shares are trading higher after the company announced the FDA has accepted its new drug application for ET-600.
